APDN - アプライドDNAサイエンシス (Applied DNA Sciences Inc) アプライドDNAサイエンシス

 APDNのチャート


 APDNの企業情報

symbol APDN
会社名 Applied DNA Sciences Inc (アプライドDNAサイエンシス)
分野(sector) Consumer Services   消費者サービス
産業(industry) Other Consumer Services  
業種 化学_特殊化学製品   工業(Industrials)
概要 事業概要 Applied DNA Sciences Inc. is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA SigNature T DNA fiberTyping DNAnet digitalDNA SigNify and Beacon. Its SigNify IF portable DNA reader provides definitive real-time authentication of SigNature DNA in the field-DNA becomes a solution for supply chain integrity. SigNature DNA is the Company''s platform ingredient at the core of all its security solutions. It provides forensic power and protection for a range of applications. SigNature T DNA is a tagging and authentication system specifically designed for textiles and apparel. DNAnet is a DNA marker that can be used to definitively link evidence and offenders to specific crime scenes and help return stolen or lost property to its rightful owner.   アプライドDNAサイエンシスは、米国のDNAセキュリティ―ソリュ―ション会社。製品、ブランド、知的財産権の偽造や転用を防ぐため、北米と欧州で、DNAタグを利用した偽造防止技術を供給する。主な製品は、「SigNatureDNA」、「fiberTyping」、「 DNANet」、 「digitalDNA」など。本社は、ニューヨーク州スト―ニ―ブルック。   Applied DNA is commercializing LinearDNA™, its proprietary, large-scale polymerase chain reaction ('PCR')-based manufacturing platform that allows for the large-scale production of specific DNA sequences. The LinearDNA platform has utility in the nucleic acid-based in vitro diagnostics and preclinical nucleic acid-based drug development and manufacturing market. The platform is used to manufacture DNA for customers as components of in vitro diagnostic tests and for preclinical nucleic acid-based drug development in the fields of adoptive cell therapies (CAR T and TCR therapies), DNA vaccines (anti-viral and cancer), RNA therapies, clustered regularly interspaced short palindromic repeats (CRISPR) based therapies, and gene therapies. Applied DNA has also established a COVID-19 diagnostic and testing offering that is in the early stages of commercialization and is grounded in the Company's deep expertise in DNA. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others.
本社所在地 50 Health Sciences Drive Stony Brook NY 11790 USA
代表者氏名 James A. Hayward ジェームズ・A・ヘイワード
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 631-240-8800
設立年月日 1983年
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 60人
url www.adnas.com
nasdaq_url https://www.nasdaq.com/symbol/apdn
adr_tso
EBITDA EBITDA(百万ドル) -10.19729
終値(lastsale) 1.42
時価総額(marketcap) 42759120.94
時価総額 時価総額(百万ドル) 43.36136
売上高 売上高(百万ドル) 3.85349
企業価値(EV) 企業価値(EV)(百万ドル) 40.84654
当期純利益 当期純利益(百万ドル) -11.07232
決算概要 決算概要 BRIEF: For the nine months ended 30 June 2018 Applied DNA Sciences Inc revenues decreased 25% to $2.7M. Net loss decreased 18% to $8.2M. Revenues reflect United States (Country) segment decrease of 58% to $1.1M Europe segment decrease of 17% to $799K. Lower net loss reflects Selling general and administrative decrease of 29% to $7.5M (expense) Depreciation and amortization decrease of 13% to $426K (expense).

 APDNのテクニカル分析


 APDNのニュース

   Applied DNA to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT  2022/03/23 16:00:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN), a leader in cell-free, enzymatic DNA production, today announced that CEO Dr. James A. Hayward is invited to present at the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest, on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT. Dr. Hayward’s presentation will be available on-demand for the duration of the conference via the sign-up link: Sign up here to access the presentation During th
   Applied DNA Sciences gains on U.S. regulatory nod for COVID-19 sample kit  2022/03/09 17:12:18 Seeking Alpha
The shares of life sciences company, Applied DNA Sciences <> are rising on Wednesday amid reports that the U.S
   Applied DNA Raises $4.2M Via Registered Direct Offering  2022/02/25 13:12:53 Benzinga
Applied DNA Sciences, Inc. (NASDAQ: APDN ) a polymerase chain reaction based DNA manufacturer , closed its previously announced registered direct offering with an institutional investor of 1.5 million shares of common stock at a price of $2.80 per share for gross proceeds of approximately $4.2 million , before deducting the placement agent’s fees and other offering expenses payable by the company. In a concurrent private placement, Applied DNA also issued to the institutional investor in the offering unregistered … Full story available on Benzinga.com
   Applied DNA stock falls on pricing ~$4.2M share offering  2022/02/22 13:19:56 Seeking Alpha
Applied DNA Sciences (APDN) has dropped -12.80% pre-market after pricing its share offering.The company entered into a securities purchase agreement with an institutional investor for
   Applied DNA Sciences, Inc.''s (APDN) CEO James Hayward on Q1 2022 Results - Earnings Call Transcript  2022/02/10 23:58:04 Seeking Alpha
   Applied Dna Sciences Inc Shares Fall 5.8% Below Previous 52-Week Low - Market Mover  2021/12/29 06:56:58 Kwhen Finance
Applied Dna Sciences Inc (APDN) shares closed 5.8% lower than its previous 52 week low, giving the company a market cap of $34M. The stock is currently down 10.2% year-to-date, down 15.5% over the past 12 months, and down 94.0% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%. Trading Activity Trading volume this week was 67.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -130.3% The company's stock price performance over the past 12 months lags the peer average by -146.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Applied DNA Sciences (NASDAQ:APDN) Upgraded by Zacks Investment Research to Hold  2021/12/21 22:16:45 Dakota Financial News
Applied DNA Sciences (NASDAQ:APDN) was upgraded by Zacks Investment Research from a sell rating to a hold rating in a note issued to investors on Tuesday, Zacks.com reports. According to Zacks, Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, []
   HC Wainwright Trims Applied DNA Sciences (NASDAQ:APDN) Target Price to $8.00  2021/12/11 11:32:41 Transcript Daily
Applied DNA Sciences (NASDAQ:APDN) had its price objective cut by HC Wainwright from $11.00 to $8.00 in a report issued on Friday, The Fly reports. They currently have a buy rating on the technology companys stock. Separately, Zacks Investment Research downgraded shares of Applied DNA Sciences from a hold rating to a sell rating in []
   Applied DNA Sciences price target lowered at H.C. Wainwright despite revenue beat  2021/12/10 17:28:14 Seeking Alpha
   Applied DNA Sciences, Inc. (APDN) CEO James Hayward on Q4 2021 Results - Earnings Call Transcript  2021/12/10 06:56:04 Seeking Alpha
   Tonino Lamborghini Cannabis Beverages Soon Available In US & Colombia Via Deal With Flora Growth  2021/11/29 16:01:34 Benzinga
Cannabis producer Flora Growth Corp. (NASDAQ: FLGC ) announced on Monday that it has inked a licensing agreement with Tonino Lamborghini to produce and distribute Tonino Lamborghini branded cannabis beverages across North America and Colombia under their renowned luxury lifestyle brand. Under the terms of the agreement, the Miami and Toronto-based company revealed that it will retain the right of first refusal to produce and distribute any CBD or CBG products globally under the Tonino Lamborghini brand. The products will be manufactured through Flora''s division, using Applied DNA Sciences, Inc. (NASDAQ: APDN ) molecular tagging and authentication technology to ensure product verification, in line with the new age of cannabis consumer packaged goods. The company will also retain Full story available on Benzinga.com
   Thinking about buying stock in Applied DNA Sciences, Co-Diagnostics, Precipio, Beyond Air, or Chembio Diagnostics?  2021/11/29 14:31:00 Benzinga
NEW YORK , Nov. 29, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APDN, CODX, PRPO, XAIR, and CEMI. … Full story available on Benzinga.com
   Zacks: Analysts Anticipate Applied DNA Sciences, Inc. (NASDAQ:APDN) Will Post Quarterly Sales of $2.84 Million  2021/11/25 01:44:42 Transcript Daily
Wall Street brokerages expect Applied DNA Sciences, Inc. (NASDAQ:APDN) to post $2.84 million in sales for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Applied DNA Sciences earnings, with estimates ranging from $2.75 million to $2.93 million. Applied DNA Sciences reported sales of $310,000.00 in the same quarter last year, which []
   Zacks: Brokerages Expect Applied DNA Sciences, Inc. (NASDAQ:APDN) to Post -$0.32 EPS  2021/11/20 15:20:41 Dakota Financial News
Equities analysts expect Applied DNA Sciences, Inc. (NASDAQ:APDN) to report ($0.32) earnings per share (EPS) for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Applied DNA Sciences earnings, with the lowest EPS estimate coming in at ($0.38) and the highest estimate coming in at ($0.25). Applied DNA Sciences reported earnings []
   Fascinating stocks: Applied DNA Sciences, Inc. (NASDAQ:APDN 0.52%), Bristol-Myers Squibb Company (NYSE:BMY 0.34%)  2021/11/08 01:20:06 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Fascinating stocks: Applied DNA Sciences, Inc. (NASDAQ:APDN 0.52%), Bristol-Myers Squibb Company (NYSE:BMY 0.34%) appeared first on Stocks Equity .

 関連キーワード  (化学_特殊化学製品 米国株 アプライドDNAサイエンシス APDN Applied DNA Sciences Inc)

化学産業により作られた製品は、経済の基盤を成し自動車や電機産業のほか、日用雑貨や医薬品など生活の隅々で使用されている。化学産業は経済活動の影響を受ける面が大きく、関連株も景気動向に左右される。化学産業の基礎資材は石油から作られ原油価格の影響も受けやすい。また、日本の化学産業はアジアなど海外企業との競争も激しくなっている。

 twitter  (公式ツイッターやCEOツイッターなど)